Evaluation of a New Screening Method for Sarcopenia in Rheumatoid Arthritis

NACompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

July 29, 2021

Primary Completion Date

May 16, 2024

Study Completion Date

May 16, 2024

Conditions
Rheumatoid Arthritis
Interventions
DEVICE

Microfet2®

"Conducting a day hospitalization including analyses:~1. Quantitative muscular analysis by measuring the DEXA of the whole body, the reference method for measuring body compartments and allowing the diagnosis of sarcopenia (IMMA\<7 in men and 5.5 in women)~2. Qualitative muscular analysis:~ * isokinetic measurement of muscular strength carried out on 3 muscle groups using a manual measurement sensor such as Microfet2 ® : quadriceps, triceps brachii, biceps~ * measurement of grip strength using Jamar® equipment validated as recommended by the EWGSOP~ * a walking test to assess the functional impact of sarcopenia and its severity"

Trial Locations (1)

51092

Chu Reims, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT04933097 - Evaluation of a New Screening Method for Sarcopenia in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter